Exclusion Criteria:~* Agitation symptoms are attributable to concomitant medications, adverse environmental
conditions, substance abuse, or active medical or psychiatric conditions as per Investigator's judgment;~* Has
been diagnosed with one or more of the following psychiatric conditions:~ * Schizophrenia, schizoaffective
disorder, or other psychotic disorder that is not related to Alzheimer's dementia;~ * Bipolar disorder;~ *
Major depressive disorder, unless it is considered stable and treated for at least 8 weeks prior to
Screening;~* Has a significant risk for suicidal behavior during the course of their participation in the
study, or is considered to be an imminent danger to themselves or others, in the opinion of the investigator,
and/or as assessed by Columbia Suicide Severity Rating Scale (C-SSRS); or the patient has had 1 or more suicide
attempts within the 2 years prior to Screening;~* The patient has known hypersensitivity or intolerance to
ITI-1284 or lumateperone, or to any of their excipients.
